Phaseline

Companies › PharmaIN

PharmaIN: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Gastroenterology.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Terlipressin (PHIN-214)
Vasopressin V1 receptor binding agent; Vasopressin V2 receptor binding agent
AVPR1A, AVPR1B, AVPR2Phase 1Cirrhosis, Liver–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05490888Terlipressin (PHIN-214)Phase 1Cirrhosis, LiverGastroenterologyMay 2026

Targets

AVPR1A (1) AVPR1B (1) AVPR2 (1)

Companies with the same targets

Tiohundra Otsuka Newleos Therapeutics

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.